MS
OGN icon

Marshall & Sullivan’s Organon & Co OGN Stock Holding History

Marshall & Sullivan’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-245
Closed -$6.84K – 64
2022
Q4 		$6.84K Buy
+245
New +$6.26K ﹤0.01% 84
2022
Q3 		– Sell
-245
Closed -$8K – 73
2022
Q2 		$8K Buy
+245
New +$8.58K ﹤0.01% 79

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall & Sullivan's OGN Position: Q1 2023 in Review

Marshall & Sullivan sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 245 shares — an estimated $6.84K sold.

Marshall & Sullivan first reported a position in OGN in Q2 2022 and held it in 2 quarters. The position peaked at $8K in Q2 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Marshall & Sullivan reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Marshall & Sullivan sold 245 Organon & Co shares in Q1 2023, an estimated $6.84K.
  • Marshall & Sullivan first reported a position in Organon & Co in Q2 2022 and held it in 2 quarters.
  • Marshall & Sullivan's Organon & Co position peaked at $8K in Q2 2022.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Marshall & Sullivan's 13F filing for Q1 2023, filed 10 Apr 2023.